A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding only to cancer cells and not to the related antigen IL13Rα1, which is ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Jeffrey Wong, MD, discusses the unmet needs in prostate cancer treatment, especially in regard to radiopharmaceuticals.

CAR T-cell therapy reprograms a patient's immune cells to target and destroy cancer cells, offering a promising treatment for ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

A project to manufacture nanomaterials that could provide new treatments for osteoarthritis and cancer joins a trio of investigations funded by the U.S. National Science Foundation (NSF) and more on ...

"I wanted to create a new light accessory to help keep you visible and safe at night," said an inventor, from Fort Worth, Texas, "so I invented the WALKING SAFETY LIGHT SAVER. My design ensures the ...

GSK's Blenrep (belantamab mafodotin) has officially been approved by the UK's Medicines and Healthcare products Regulatory ...

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...

Prostate cancer has long been one of Canada’s most prevalent, yet under-discussed health threats. It is the most commonly ...